PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VERA vs. CDNS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VERA and CDNS is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

VERA vs. CDNS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vera Therapeutics, Inc. (VERA) and Cadence Design Systems, Inc. (CDNS). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-30.31%
4.69%
VERA
CDNS

Key characteristics

Sharpe Ratio

VERA:

-0.61

CDNS:

0.01

Sortino Ratio

VERA:

-0.65

CDNS:

0.27

Omega Ratio

VERA:

0.92

CDNS:

1.03

Calmar Ratio

VERA:

-0.81

CDNS:

0.01

Martin Ratio

VERA:

-1.85

CDNS:

0.02

Ulcer Index

VERA:

19.65%

CDNS:

11.81%

Daily Std Dev

VERA:

59.77%

CDNS:

35.78%

Max Drawdown

VERA:

-84.89%

CDNS:

-93.13%

Current Drawdown

VERA:

-44.80%

CDNS:

-9.59%

Fundamentals

Market Cap

VERA:

$2.16B

CDNS:

$81.23B

EPS

VERA:

-$2.10

CDNS:

$3.78

Total Revenue (TTM)

VERA:

$0.00

CDNS:

$3.29B

Gross Profit (TTM)

VERA:

$952.00K

CDNS:

$2.96B

EBITDA (TTM)

VERA:

-$103.90M

CDNS:

$1.12B

Returns By Period

In the year-to-date period, VERA achieves a -35.07% return, which is significantly lower than CDNS's -1.75% return.


VERA

YTD

-35.07%

1M

-17.71%

6M

-27.03%

1Y

-40.25%

5Y*

N/A

10Y*

N/A

CDNS

YTD

-1.75%

1M

-3.41%

6M

4.69%

1Y

1.68%

5Y*

29.97%

10Y*

32.03%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VERA vs. CDNS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VERA
The Risk-Adjusted Performance Rank of VERA is 1111
Overall Rank
The Sharpe Ratio Rank of VERA is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of VERA is 1616
Sortino Ratio Rank
The Omega Ratio Rank of VERA is 1717
Omega Ratio Rank
The Calmar Ratio Rank of VERA is 44
Calmar Ratio Rank
The Martin Ratio Rank of VERA is 11
Martin Ratio Rank

CDNS
The Risk-Adjusted Performance Rank of CDNS is 4242
Overall Rank
The Sharpe Ratio Rank of CDNS is 4444
Sharpe Ratio Rank
The Sortino Ratio Rank of CDNS is 3838
Sortino Ratio Rank
The Omega Ratio Rank of CDNS is 3737
Omega Ratio Rank
The Calmar Ratio Rank of CDNS is 4444
Calmar Ratio Rank
The Martin Ratio Rank of CDNS is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VERA vs. CDNS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vera Therapeutics, Inc. (VERA) and Cadence Design Systems, Inc. (CDNS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VERA, currently valued at -0.61, compared to the broader market-2.000.002.004.00-0.610.01
The chart of Sortino ratio for VERA, currently valued at -0.65, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.650.27
The chart of Omega ratio for VERA, currently valued at 0.92, compared to the broader market0.501.001.502.000.921.03
The chart of Calmar ratio for VERA, currently valued at -0.81, compared to the broader market0.002.004.006.00-0.810.01
The chart of Martin ratio for VERA, currently valued at -1.85, compared to the broader market-10.000.0010.0020.0030.00-1.850.02
VERA
CDNS

The current VERA Sharpe Ratio is -0.61, which is lower than the CDNS Sharpe Ratio of 0.01. The chart below compares the historical Sharpe Ratios of VERA and CDNS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.61
0.01
VERA
CDNS

Dividends

VERA vs. CDNS - Dividend Comparison

Neither VERA nor CDNS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

VERA vs. CDNS - Drawdown Comparison

The maximum VERA drawdown since its inception was -84.89%, smaller than the maximum CDNS drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for VERA and CDNS. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-44.80%
-9.59%
VERA
CDNS

Volatility

VERA vs. CDNS - Volatility Comparison

Vera Therapeutics, Inc. (VERA) has a higher volatility of 24.85% compared to Cadence Design Systems, Inc. (CDNS) at 13.29%. This indicates that VERA's price experiences larger fluctuations and is considered to be riskier than CDNS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
24.85%
13.29%
VERA
CDNS

Financials

VERA vs. CDNS - Financials Comparison

This section allows you to compare key financial metrics between Vera Therapeutics, Inc. and Cadence Design Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab